Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 0.80 |
| ▸ | CCR8 | P51685 | 5/20 | 0.80 |
| ▸ | LMNA | P02545 | 4/20 | 0.80 |
| ▸ | CCR5 | P51681 | 3/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.80 |
| ▸ | MMP2 | P08253 | 2/20 | 0.80 |
| ▸ | TSHR | P16473 | 2/20 | 0.80 |
| ▸ | MAPT | P10636 | 2/20 | 0.80 |
| ▸ | HTT | P42858 | 2/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.80 |
| ▸ | GMNN | O75496 | 1/20 | 0.80 |
| ▸ | TP53 | P04637 | 1/20 | 0.80 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.80 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.80 |
| ▸ | MMP9 | P14780 | 1/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.80 |
| ▸ | MMP8 | P22894 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenanthroline SCHEMBL30851477 | 1.00 | CCR1 (0.80) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL29354015 | 0.89 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL29367277 | 0.89 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL8312 | 0.89 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL8845760 | 0.89 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL2813173 | 0.87 | CCR1 (0.84) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL30945289 | 0.87 | CCR1 (0.84) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL22982126 | 0.87 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL21044608 | 0.87 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL3812011 | 0.87 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747238-A1 | PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS | Sanofi (FR) | 2026-05-27 | — | — | EP | claimed |
| WO-2025021696-A1 | PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS | SANOFI (FR) | 2025-01-30 | — | — | WO | claimed |
| US-9611337-B2 | Chain transfer agent, photosensitive composition, cured product of photosensitive composition, and method for curing photosensitive composition | AUTONETWORKS TECHNOLOGIES, LTD. (JP) | 2017-04-04 | — | — | US | claimed |
| US-20240360344-A1 | CHEMICAL-RESISTANT, REACTIVE, PRESSURE-SENSITIVE ADHESIVE TAPE | TESA SE (DE) | 2024-10-31 | — | — | US | disclosed |
| WO-2024190525-A1 | COLORED CURABLE RESIN COMPOSITION, OPTICAL FILTER, AND SOLID-STATE IMAGING ELEMENT | 住友化学株式会社 | 2024-09-19 | — | — | WO | disclosed |
| US-12049465-B2 | Tricyclic compounds and their use as phosphodiesterase inhibitors | PFIZER INC. (US) | 2024-07-30 | — | — | US | disclosed |
| WO-2024097736-A1 | PROCESSES FOR PREPARING AZOLOPYRIMIDINE COMPOUNDS | ARCUS BIOSCIENCES, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| US-20230146535-A1 | TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | PFIZER INC. (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230002386-A1 | TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | PFIZER INC. (US) | 2023-01-05 | — | — | US | disclosed |
| US-11472805-B2 | Tricyclic compounds and their use as phosphodiesterase inhibitors | PFIZER, INC. (US) | 2022-10-18 | — | — | US | disclosed |
| EP-3766885-B1 | TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | PFIZER (US) | 2022-05-25 | — | — | EP | disclosed |
| US-9090796-B2 | Organic-inorganic composite materials containing triazine rings and electrical devices using the same | HITACHI, LTD. (JP) | 2015-07-28 | — | — | US | disclosed |
| US-20130338327-A1 | CHAIN TRANSFER AGENT, PHOTOSENSITIVE COMPOSITION, CURED PRODUCT OF PHOTOSENSITIVE COMPOSITION, AND METHOD FOR CURING PHOTOSENSITIVE COMPOSITION | AUTONETWORKS TECHNOLOGIES, LTD. (JP) | 2013-12-19 | — | — | US | disclosed |
| EP-2669299-A1 | CHAIN TRANSFER AGENT, PHOTOSENSITIVE COMPOSITION, CURED PRODUCT OF PHOTOSENSITIVE COMPOSITION, AND METHOD FOR CURING PHOTOSENSITIVE COMPOSITION | AutoNetworks Technologies, Ltd. (JP) | 2013-12-04 | — | — | EP | disclosed |
| EP-2597114-A1 | Organic-inorganic composite materials containing triazine rings and electrical devices using the same | Hitachi Ltd. (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-20130131248-A1 | ORGANIC-INORGANIC COMPOSITE MATERIALS CONTAINING TRIAZINE RINGS AND ELECTRICAL DEVICES USING THE SAME | HITACHI, LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20120016152-A1 | Process for the preparation of 4`-haloalkylbiphenyl-2-carboxylic acids | SALTIGO GMBH (DE) | 2012-01-19 | — | — | US | disclosed |
| US-7910272-B2 | Dye-containing photosensitive composition, color filter using the same, and production method thereof | FUJIFILM CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20070190435-A1 | Dye-containing photosensitive composition, color filter using the same, and production method thereof | FUJIFILM CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20040185372-A1 | Dye-containing curable composition, color filter, and process of preparing color filter | FUJI PHOTO FILM CO., LTD. | 2004-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12049465-B2 | Tricyclic compounds and their use as phosphodiesterase inhibitors | PDE3B, PDE3A, PDE5A | CCR1 2143/4885CCR8 3136/4885LMNA 1280/4885 |
| US-20120016152-A1 | Process for the preparation of 4`-haloalkylbiphenyl-2-carboxylic acids | CYP4B1, HACL2, UGT1A4 | CCR1 1938/4885CCR8 2653/4885LMNA 3085/4885 |
| US-20230146535-A1 | TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | PDE3B, PDE3A, PDE5A | CCR1 2143/4885CCR8 3136/4885LMNA 1280/4885 |
| US-11472805-B2 | Tricyclic compounds and their use as phosphodiesterase inhibitors | PDE3B, PDE3A, PDE5A | CCR1 2143/4885CCR8 3136/4885LMNA 1280/4885 |
| US-20230002386-A1 | TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | PDE3B, PDE3A, PDE5A | CCR1 2143/4885CCR8 3136/4885LMNA 1280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.